NCT03890432View on ClinicalTrials.gov

GLUCOSAFE 2 - A New Tool for Nutritional Management and Insulin-therapy in the Intensive Care Unit (ICU)

NACompletedINTERVENTIONAL
Enrollment

213

Participants

Timeline

Start Date

January 10, 2023

Primary Completion Date

January 26, 2025

Study Completion Date

January 26, 2025

Conditions
Critical IllnessEnergy Supply; Deficiency, SevereProtein DeficiencyHypoglycemiaHyperglycemia
Interventions
DEVICE

GLUCOSAFE 2

Use of GLUCOSAFE 2 software for nutrition management and insulin-therapy

DEVICE

Local protocol control group with routine care

Use of the local protocols (electronic or paper version) for nutrition management and blood glucose control.

DEVICE

Historical control group with routine care

Use of the local protocols (electronic or paper version) for nutrition management and blood glucose control.

Trial Locations (2)

1205

Hôpitaux Universitaire de Genève, Geneva

1211

Service of Intensive Care, Geneva University Hospital,, Geneva

All Listed Sponsors
collaborator

Aalborg University

OTHER

lead

HEIDEGGER CP

OTHER